Business & Finance
CRH Medical achieves higher revenues of USD24.67m for Q1 2018
1 May 2018 -

Gastrointestinal diseases company CRH Medical Corporation (TSX:CRH) (NYSE MKT:CRHM) disclosed on Monday its financial results for the quarter ended 31 March 2018.

Revenues of USD24.67m were generated for the three months ended 31 March 2018, a growth over revenues of USD21.369m for the three months ended 31 March 2017.

Total adjusted operating EBITDA of USD12,414m was announced for the three months ended 31 March 2018, a rise of USD1.366m from the same period in 2017.

Adjusted operating expenses of USD12.25m were reported for the three months ended 31 March 2018, up versus USD10.32m for the three months ended 31 March 2017, which was primarily related to adjusted operating expenses in the anaesthesia services business.

Login
Username:

Password: